Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate

Prostate

Volumn 35, Issue 3, 1998, Pages 212-220

  Dirnhofer, S ^a,b   Berger, C ^a,c   Hermann, M ^a   Steiner, G ^d   Madersbacher, S ^a,d   Berger, P ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Benign prostatic hyperplasia; Follicle stimulating hormone; Human chorionic gonadotropin; Prostate cancer; Receptors

Indexed keywords

FOLLITROPIN; GLYCOPROTEIN; GONADOTROPIN; LUTEINIZING HORMONE; STEROID HORMONE;

ARTICLE; DATA ANALYSIS; ENZYME ANALYSIS; FLUOROMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; LUTEINIZING HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FLUORESCENT ANTIBODY TECHNIQUE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; LUTEINIZING HORMONE; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, FSH; RECEPTORS, LH; TUMOR CELLS, CULTURED;

EID: 0032524950     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980515)35:3<212::AID-PROS7>3.0.CO;2-I     Document Type: Article

References (36)

1. Boyle P, Garraway M, Fang-Liu G, Guess HA, O'Leary MP, Oishi K, Tsukamoto T, Sagnier PP: Epidemiology and natural history of BPH. In Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds): "The Second International Consultation on Benign Prostatic Hyperplasia (BPH)," Vol 19, S.C.I., 1993:19-34.
2. Gittes R: Carcinoma of the prostate. N Engl J Med 1991;324:236-245.
3. Wingo PA, Tong T, Bolden S: Cancer statistics. CA Cancer J Clin 1995;45:8-30 [published erratum appears in CA Cancer J Clin 1995;45:127-128].
4. Krieg M, Nass R, Tunn S: Effect of aging on endogenous level of 5-alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human ptostate. J Clin Endocrinol Metab 1993;77:375-381.
5. Oesterling JE, Juniewicz PE, Walters JR, Strandberg JD, Steele RE, Ewing LL, Coffey DS: Aromatase inhibition in the dog. II. Effect on growth, function and pathology of the prostate. J Urol 1988;139:832-839.
6. Griffiths K: Molecular control of prostate growth. In Kirby R, McConnel JD, Fitzpatrick JM, Roehrborn CG, Boyle P (eds): "Textbook of Benign Prostatic Hyperplasia," Oxford: ISIS Medical Media, 1996:23-57.
7. di Sant'Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic and therapeutic implications. Cancer 1992;70:254-268.
8. Tao YX, Lei ZM, Woodworth SH, Rao CHV: Novel expression of luteinizing hormone/chorionic gonadotropin receptor gene in rat prostates. Mol Cell Endocrinol 1995;111:9-12.
9. Rao CV, Li X, Lei ZM, Toth P, Cook VD: Novel expression of functional human chorionic gonadotropin/luteinizing hormone receptor gene in human umbilical cords. J Clin Endocrinol Metab 1993;77:1706-1714.
10. Berger P, Kranewitter W, Madersbacher S, Gerth R, Geley S, Dirnhofer S: Eutopic production of human chorionic gonadotropin beta (hCGbeta) and luteinizing hormone beta (hLHbeta) in the human testis. FEBS Lett 1994;343:229-233.
11. Madersbacher S, Stulnig T, Schönitzer D, Huber LA, Wick G, Dirnhofer S, Berger P: Serum glycoprotein hormones and their free alpha-subunit in a healthy elderly population selected according to the SENIEUR protocol. Analyses with ultrasensitive time resolved fluoroimmunoassays. Mech Ageing Dev 1993;71: 223-233.
12. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW: Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-461.
13. Boothby M, Ruddon RW, Anderson C, McWilliams D, Boime I: A single gonadotropin alpha-subunit gene in normal tissue and tumor-derived cell lines. J Biol Chem 1981;256:5121-5128.
14. Talmadge K, Vamvakopoulos NC, Fiddes JC: Evolution of the genes for the beta subunits of human chorionic gonadotropin and luteinizing hormone. Nature 1984;307:37-40.
15. Loosfelt H, Misrahi M, Salesse R, Atger M, Jolivet A, Thi MT, Sar S, Giuchon-Mantel A, Garnier J, Jallal B, Milgrom E: Cloning and sequencing of porcine LH-hCG Receptor cDNA: Variants lacking transmembrane domain. Science 1989;245:525-528.
16. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
17. Dirnhofer S, Berger C, Untergasser G, Geley S, Berger P: Human beta-actin retropseudogenes interfere with RT-PCR. Trends Genet 1995;11:380-381.
18. Madersbacher S, Kratzik C, Gerth R, Dirnhofer S, Berger P: Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of testicular cancer patients: Insights into the in vivo hCG secretion pattern. Cancer Res 1994; 54:5096-5100.
19. Frazier AL, Robbins LS, Sprengel R, Stork PJ, Cone R, Segaloff DL: Isolation of TSH and LH/CG receptor cDNAs from human thyroid: Regulation by tissue specific binding. Mol Endocrinol 1990;4:1264-1276.
20. Reshef E, Lei ZM, Rao DHV, Pridham DD, Chegini N, Luborsky JL: The presence of gonadotropin receptors in non pregnant human uterus, human placenta, fetal membranes and decidua. J Clin Endocrinol Metab 1990;77:863-872.
21. Lei ZM, Toth P, Rao CV, Pridham D: Novel coexpression of human chorionic gonadotropin (hCG) human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 1993;77:863-872.
22. Lei ZM, Rao CV, Licht P, Kornyei JL, Hiatt ES: Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 1993;132:2262-2270.
23. Reiter E, McNamara M, Hennen G, Closset J: Expression and functionality of luteinizing hormone/chorionic gonadotropin receptor in the rat prostate. Endocrinology 1995;136:917-923.
24. Marcillac I, Troalen F, Ghillani P, Bidart JM, Escudier B, Ribrag V, Droz JP, Malassagne B, Rougier P, Lhommé C, Prade M, Duvillard P, Richard F, Lugagne PM, Bohoun C, Poynard T, Bellet D, Wands J: Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901-3907.
25. Alfthan H, Haglund C, Stenman UH, Dabek J: Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and non pregnant women. Clin Chem 1992;38:1981-1987.
26. Hoermann R, Spoettl G, Berger P, Mann K: Immunoreactive human chorionic beta core fragment in human pituitary. Exp Clin Endocrinol 1995;103:324-331.
27. Dirnhofer S, Hermann M, Hittmair A, Hoermann R, Kapelari K, Berger P: Expression of the human chorionic gonadotropin-beta gene cluster in human pituitaries and alternate use of exon 1. J Clin Endocrinol Metab 1996;81:4212-4217.
28. Zhang FP, Markkula M, Toppari J, Huhtaniemi I: Novel expression of luteinizing hormone subunits genes in the rat testis. Endocrinology 1995;136:2904-2912.
29. Hurkadli KS, Shet AR, Doctor VM, Garde SV, Shet NA: Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates. Br J Cancer 1990;61:225-229.
30. Radlmaier A, Eickenberg HU, Fletcher MS, Fourcade RO, ReisSantos JM, van Aubel OG, Bono AV: Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Prostate 1996;29:199-208.
31. Gingell JC, Knonagel H, Kurth KH, Tunn UW: The Schering 90.062 Study Group: Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. J Urol 1995;154:399-401.
32. Denis LJ, Pagano F, Robertson C, Nonis A, Boyle P: Double-blind, randomized, placebo-controlled trial of mepartricin in the treatment of BPH: Final results after 6 months follow up. J Urol 1997;157:136 [abstract].
33. Brodie AM, Son C, King DA, Meyer KM, Inkster SE: Lack of evidence for aromatase in human prostatic tissues: Effect of 4-hydroxyandrostendione and other inhibitors on androgen metabolism. Cancer Res 1989;49:6551-6555.
34. Smith CM, Ballard SA, Worman N, Buettner R, Masters JRW: 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro. J Clin Endocrinol Metab 1996;81:1361-1366.
35. Harada N, Utsumi T, Takagi Y: Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exon 1 in carcinogenesis. Proc Natl Acad Sci USA 1993;90: 11312-11316.
36. Gillott DJ, Iles RK, Chard T: The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 1996;73:323-326.